参考文献/References:
[1]Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet,2020,396(10251):635-648.
[2]Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin,2021,71(3):209-249.
[3]Shitara K, Chin K, Yoshikawa T, et al. Phase Ⅱ study of adjuvant chemotherapy of S1 plus oxaliplatin for patients with stage Ⅲ gastric cancer after D2 gastrectomy. Gastric Cancer,2017,20(1):175-181.
[4]Isobe Y, Nashimoto A, Akazawa K, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer,2011,14(4):301-316.
[5]Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc,2021,33(1):4-20.
[6]Hatta W, Gotoda T, Koike T, et al. History and future perspectives in Japanese guidelines for endoscopic resection of early gastric cancer. Dig Endosc,2020,32(2):180-190.
[7]北京市科委重大项目《早期胃癌治疗规范研究》专家组:早期胃癌内镜下规范化切除的专家共识意见(2018,北京).中华消化内镜杂志,2019,36(6):381-392.
[8]Cho CJ, Ahn JY, Jung HY, et al. The incidence and locational predilection of metachronous tumors after endoscopic resection of highgrade dysplasia and early gastric cancer. Surg Endosc,2017, 31(1):389-397.
[9]Arantes V, Uedo N, Salgado Pedrosa M. Polypoid nodular scar after endoscopic submucosal dissection in the gastric antrum. Rev Gastroenterol Mex,2017,82(3):267-269.
[10]Arantes V, Uedo N, Pedrosa MS, et al. Clinical relevance of aberrant polypoid nodule scar after endoscopic submucosal dissection. World J Gastrointest Endosc,2016,8(17):628.
[11]Arantes V, Uedo N, Morita Y, et al. Polypoid nodule scar after gastric endoscopic submucosal dissection: results from a multicenter study. Endosc Int Open,2018,6(10):E1198-E1203.
[12]杨津,秦斌,朱洪怡,等.内镜热损伤术后息肉样结节瘢痕的病理性质及处理策略探讨.中国内镜杂志,2022,28(4):81-85.
[13]Kim IS, Shin SJ, Noh CK, et al. Comparisons of the mucosal healing process between flat and protruded type after endoscopic submucosal dissection for gastric neoplasms. Digestion,2019,99(3):219-226.
[14]Arantes V, Uedo N. Polypoid nodule scar after gastric endoscopic submucosal dissection: Not so uncommon after resection of neoplasms located in the antrum. Digestion,2021,102(3):499-501.
[15]Arantes V, Uedo N. Criteria to characterize polypoid nodule scar after gastric endoscopic submucosal dissection in order to differentiate it from tumor recurrence. Turk J Gastroenterol,2021, 32(1):106-107.
[16]Ito S, Mizobuchi T, Shimizu I, et al. An elevated type of gastric ulcer scar in patients treated with cimetidine. Endoscopy,1986,18(1):7-9.
[17]Nakamura T, Tsukamoto Y, Yamanaka T, et al. A study onthe whitish protrusion appearing in the base of peptic ulcer duringthe administration of proton pump inhibitor. Gastroenterol Endosc,1992,34:1548-1554.
[18]Ashida K, Osaka N, Tei H, et al. Studies on the mechanism of the protrusion of the base of the ulcer during the administration of omeprazole.Gastroenterol Endosc,1989,31:1776-1782.
[19]Okazaki M, Shimizu I, Ishikawa M, et al. Gastric mucosal levels of prostaglandins and leukotrienes in patients with gastric ulcer after treatment with rabeprazole in comparison to treatment with ranitidine. J Med Invest,2007,54(1-2):83-90.
[20]Wallace JL, Devchand PR. Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense. Br J Pharmacol,2005,145(3):275-282.
[21]Brzozowski T, Konturek PC, Konturek SJ, et al. Involvement of cyclooxygenase (COX)2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor. J Physiol Pharmacol,2000, 51(4 Pt 1):751-773.
[22]Sakai Y, Fujita K, Sakai H, et al. Prostaglandin E2 regulates the expression of basic fibroblast growth factor messenger RNA in normal human fibroblasts. Kobe J Med Sci,2001,47(1):35-45.
[23]Horikawa Y, Mimori N, Mizutamari H, et al. Proper muscle layer damage affects ulcer healing after gastric endoscopic submucosal dissection. Dig Endosc,2015,27(7):747-753.
[24]Yoshizawa Y, Sugimoto M, Sato Y, et al. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial. Dig Endosc,2016,28(2):162-172.
[25]Jung DH, Park JC, Lee YC, et al. Comparison of the efficacy of polaprezinc plus proton pump inhibitor and rebamipide plus proton pump inhibitor treatments for endoscopic submucosal dissectioninduced ulcers. J Clin Gastroenterol,2021, 55(3):233-238.
[26]Pickhardt PJ, Asher DB. Wall thickening of the gastric antrum as a normal finding: multidetector CT with cadaveric comparison. AJR Am J Roentgenol,2003,181(4):973-979.
[27]Kato M, Yahagi N. Do we need to take care of nodular scar following gastric ESD? Endosc Int Open,2018,6(10):E1204-E1205.